Navigation Links
Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
Date:4/15/2008

SAN DIEGO, April 15 /PRNewswire/ -- Pacira Pharmaceuticals, Inc. today announced a collaboration with Amylin Pharmaceuticals, Inc. for the development of sustained release injectable products based on the DepoFoam(R) technology platform from Pacira. The companies will work together to enhance the dosing profile for compounds within Amylin's early research and development pipeline. The goal of the collaboration is to develop multiple products based on sustained release, subcutaneous injection.

Dave Stack, President and CEO of Pacira stated, "In addition to our own lead development candidate, DepoBupivacaine(TM), we believe that delivery of Amylin's compounds using the DepoFoam(R) technology would create significant value for patient care, our partners, and Pacira."

"Pacira's DepoFoam(R) technology is an attractive delivery system and Amylin is excited to apply this technology to our peptide and protein therapeutics platform," said Christopher Rhodes, Ph.D., Executive Director, Pharmaceutical Sciences of Amylin. "This collaboration fits well with Amylin's research and development activities, which leverage our expertise in metabolism to develop potential therapies for diabetes and obesity."

Terms of the agreement are not disclosed at this time.

About Pacira

Pacira is an acute care specialty pharmaceutical company with a primary focus on developing Products which satisfy the needs of our customers in the institutional marketplace. The Company utilizes DepoFoam(R) delivery technology to cost-effectively improve patient care through enhanced dosing and administration profiles. Currently, the Company is developing DepoBupivacaine(TM) in phase III clinical studies for postsurgical pain. Revenues are generated from two approved products which are marketed by partners: DepoCyt(R) for lymphomatous meningitis and DepoDur(R) for post- surgical pain. Additional information about Pacira is available at '/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
2. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
3. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
4. Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt
5. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
6. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
7. Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations
8. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
9. Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
Breaking Biology Technology:Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3
...CET, AMSTERDAM, February 20 Amsterdam Molecular,...d of human gene therapy,today reported its full ye..., raising gross proceeds of EUR 55.7 million - Ca...30, 2007 - U.S. FDA orphan drug designation for l.../II in LPL type I deficiency - Pre-registration t...
...emonstrated by a collaboration between researchers...logy (NIST), Penn State and the University of Kent...duce large arrays of organic electronic transistor...ns including flexible displays, intelligent paper ...diagnostics. , In a paper posted this week,* the ...
...ion,(Nasdaq: KNSY ) is scheduled to present at th... at the Mission Bay Conference Center in San,Franc..., Kensey Nash,s Chief Operating Officer, will deli...ately at 2:50 p.m. (PT). The,presentation material...p://www.kenseynash.com ) beginning at 2:50 p.m. (P...
Other Biology Technology:Amsterdam Molecular Therapeutics Reports Full Year Results 2007 2Amsterdam Molecular Therapeutics Reports Full Year Results 2007 3Amsterdam Molecular Therapeutics Reports Full Year Results 2007 4Amsterdam Molecular Therapeutics Reports Full Year Results 2007 5Amsterdam Molecular Therapeutics Reports Full Year Results 2007 6Amsterdam Molecular Therapeutics Reports Full Year Results 2007 7Directed self-ordering of organic molecules for electronic devices 2
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Grooving down the helix 2Grooving down the helix 3Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 5403 1Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 5403 2Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 5403 3News brief 3A Effects of aspirin and folic acid on inflammation markers for colorectal adenomas 59312 1Drop in Certain Visual Skills May Precede Alzheimers 59310 1Drop in Certain Visual Skills May Precede Alzheimers 59310 2
...pression of genes may be the reason why people who...ckly develop a tolerance, biologists at The Univer...eam, led by graduate student Yan Wang, used the fr...to determine how the nervous system becomes tolera...The team,s work appears in the October 16 issue of...
...ore acid, with potentially devastating consequence...eefs and provide much of the Earths breathable oxy...up of carbon dioxide (CO 2 ) in the atmosphere, di... be lethal for animals with chalky skeletons which...ife. , Acid oceans will be among the issues explo...
...DED BROKERAGE TO UTILIZE TITANIUM,S ... Oct. 16 Titanium Group, Ltd,(OTC Bulletin Board:...s,provider announced today that it has signed a co...) (SHA: 600837). Titanium will install its,Biometr...ated office in,Hong Kong. Haitong, listed in the S...
Other Biology News:Tolerance to inhalants may be caused by changes in gene expression 2Acid oceans warning 2Titanium Group Announces Contract With Haitong Securities 2Titanium Group Announces Contract With Haitong Securities 3Titanium Group Announces Contract With Haitong Securities 4
Mouse Anti-Human ACP2 Monoclonal Antibody, Unconjugated, Clone M1-4A12 from Novus Biologicals
Mouse Anti-Human DCAMKL2 Monoclonal Antibody, Unconjugated, Clone 2A5 from Novus Biologicals
...ew IKATUBE ULTRA TURRAX Tube Disperser System from... system. It offers a cleaner, safer, and more effi...processes sample volumes from 2 to 15 ml inside se...chers can choose one of 4 different tube types. Ea...
...ewest member of Wyatt Technology's family of light...our high temperature chromatograph and enables you...rmoplastic polymers. The HTmD is easily installed ... 2000 device and enables you to get three angles o...
Biology Products: